These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 742116)

  • 1. [Behavior of urinary secretion and plasma levels of various cardiac glycosides at the time of hospital admission].
    Ochs HR; Bodem G; Otten H; Meyer R; Baur MP
    Verh Dtsch Ges Inn Med; 1978; (84):749-52. PubMed ID: 742116
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cardiac glycosides and clinical consequences].
    Rietbrock N; Kuhlmann J; Vöhringer HF
    Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism and kinetics of -acetyldigoxin].
    Ruiz-Torres A; Burmeister H
    Klin Wochenschr; 1972 Feb; 50(4):191-5. PubMed ID: 5011551
    [No Abstract]   [Full Text] [Related]  

  • 5. Biliary excretion of cardiac glycosides.
    Russell JQ; Klaassen CD
    J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Direct determination of intestinal absorption of tritium-labelled cardiac glycosides by measurement of portal and arterial concentrations and volume of portal vein flow in guinea pigs].
    Haass A; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):343. PubMed ID: 4253785
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the blood level and secretion of radioactively labeled cardiac glycosides following intraduodenal application in the cat].
    Lahrtz H; Sattler RW; van Zwieten PA
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 148(3):210-22. PubMed ID: 5728874
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacology of cardiac glycosides].
    Noack E
    Med Klin; 1971 Apr; 66(16):583-6. PubMed ID: 4251818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma levels and electrocardiogram after intravenous administration of proscillaridin and digoxin].
    Belz GG; Rudofsky G; Lossnitzer K; Wolf G; Sauch M
    Z Kardiol; 1974 Mar; 63(3):201-11. PubMed ID: 4471866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac glycosides].
    Sova J
    Vnitr Lek; 1975 Jun; 21(6):605-15. PubMed ID: 1136209
    [No Abstract]   [Full Text] [Related]  

  • 12. On the plasma protein binding of 16-acetyl-gitoxin.
    Hüller G; Haustein KO; Murawski D
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):200-2. PubMed ID: 7251233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on the uptake of cardiac glycosides by the cell].
    Hüsten J; Ruiz-Torres A
    Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significant plasma digoxin concentration in patients at the time of hospital admission].
    Lichey J; Schröder R; Rietbrock N
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1712-5. PubMed ID: 1030088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism and intestinal absorption of cardiac glycosides].
    Lauterbach F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities and problems or long-term therapy using cardiac glycosides].
    Gillmann H
    Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
    Rietbrock N
    Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
    Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
    Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of digitalemia for a correct therapeutic attitude using cardioactive glycosides].
    Pretolani E; Baraghini F; Zoli I
    Quad Sclavo Diagn; 1975 Jun; 11(2):266-71. PubMed ID: 1223938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.